CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz.
Talent pool access due to close proximity to Basel, a renowned pharma and biotech hub at the crossroads of Germany, France, and Switzerland, ensuring access to highly skilled professionals.
and solid-phase peptide synthesis (SPPS), Granules explained in a press release. Although Granules didn’t disclose the sale price, The Economic Times reported the price tag at 20 million Swiss ...
Cambridge synthetic biology doyen Constructive Bio has been awarded a significant grant from Innovate UK to transform the ...
As part of this strategy, CordenPharma has finalized plans to establish a state-of-the-art peptide manufacturing facility in ...
and large-scale peptide production with small- to large-scale Solid Phase Peptide Synthesis (SPPS) reactors for GLP-1 and non-GLP-1 peptide projects – with a total SPPS reactor capacity of more ...
As part of this strategy, CordenPharma has finalized plans to establish a state-of-the-art peptide manufacturing facility in ...